As of December 2025 Prelude Therapeutics has a market cap of A$0.15 Billion. This makes Prelude Therapeutics the world's 9257th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 10th, 2025 the market cap of Prelude Therapeutics was reported to be: